NextCure
Beltsville
About NextCure
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $333.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nasdaq:NXTC
- Website: nextcure.com
- Phone: (240)264-1250
Industries & Categories
Biopharma, Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/nextcure-74398 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.